SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Ashina, Messoud [1 ]
Goadsby, Peter J. [2 ,3 ]
Reuter, Uwe [4 ]
Silberstein, Stephen [5 ]
Dodick, David W. [6 ]
Xue, Fei [7 ]
Zhang, Feng [7 ]
Cheng, Sunfa [7 ]
Chou, Denise E. [7 ]
Lima, Gabriel Paiva da Silva [7 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Dept Neurol,Danish Headache Ctr, Copenhagen, Denmark
[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA
[3] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[4] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[5] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[6] Mayo Clin, Dept Neurol, Scottsdale, AZ USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
CEPHALALGIA | 2020年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTV20-DP-0
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] A long-term open-label safety study of galcanezumab in Japanese patients with migraine
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Tatsuoka, Yoshihisa
    Suzuki, Norihiro
    Igarashi, Hisaka
    Nakamura, Tomomi
    Ozeki, Akichika
    Yamazaki, Hiroyoshi
    Skljarevski, Vladimir
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 721 - 733
  • [32] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [33] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [34] One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study
    Goadsby, Peter J.
    Reuter, Uwe
    Hallstroem, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Zhang, Feng
    Wright, Ian K.
    Chou, Denise E.
    Klatt, Jan
    Picard, Hernan
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2020, 95 (05) : E469 - E479
  • [35] Long-term safety and efficacy of rotigotine in patients with idiopathic RLS: 5-year results front a prospective multinational open-label follow-up study
    Hogl, I.
    Trenkwalder, C.
    Garcia-Borreguero, D.
    Kohnen, R.
    Poewe, W.
    Stiasny-Kolster, K.
    Bauer, L.
    Fichtner, A.
    Schollmayer, E.
    Oertel, W.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S517 - S517
  • [36] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [37] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    [J]. EPILEPSIA, 2006, 47 : 138 - 138
  • [38] LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 435 - 435
  • [39] Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study
    Pozo-Rosich, Patricia
    Detke, Holland C.
    Wang, Shufang
    Dolezil, David
    Li, Lily Q.
    Aurora, Sheena K.
    Reuter, Uwe
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (05) : 731 - 742
  • [40] Sustained efficacy over 1 year of treatment with erenumab: results from the extension phase of the STRIVE study in episodic migraine
    Goadsby, Peter J.
    Reuter, Uwe
    Hallstrom, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Zhang, Feng
    Sapra, Sandhya
    Chou, Denise E.
    Klatt, Jan
    Picard, Hernan
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
12345